OGEN Oragenics Inc

Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.

$0.70
As of 06/21/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/20/2004
Outstanding shares:  115,638,266
Average volume:  2,188,563
Market cap:   $83,814,615
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    684023302
ISIN:        US6840233026
Sedol:      BFWK6N7

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   2.26
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%